Table 1.
Baseline characteristics of NPC patients among the CT, SRT and CT + SRT group.
| Characteristic | CT (n=114) | SRT (n=109) | CT + SRT (n=106) | P |
|---|---|---|---|---|
| Sex | ||||
| Male | 90 (78.95) | 76 (69.72) | 86 (81.13) | 0.109 |
| Female | 24 (21.05) | 33 (30.28) | 20 (18.87) | |
| Age (years) | ||||
| >40 | 85 (74.56) | 74 (67.89) | 76 (71.70) | 0.543 |
| ≤40 | 29 (25.44) | 35 (32.11) | 30 (28.30) | |
| Type of pathology | ||||
| Undifferentiated | 102 (89.47) | 96 (88.07) | 84 (79.25) | 0.066 |
| Differentiated | 12 (10.53) | 13 (11.93) | 22 (20.75) | |
| Tumor stage | ||||
| T1–T2 | 59 (51.75) | 52 (47.71) | 59 (55.66) | 0.506 |
| T3–T4 | 55 (48.25) | 57 (52.29) | 47 (44.34) | |
| LNM stage | ||||
| N0–N1 | 26 (22.81) | 26 (23.85) | 24 (22.64) | 0.974 |
| N2–N3 | 88 (77.19) | 83 (76.15) | 82 (77.36) | |
| Clinical stage | ||||
| III | 81 (71.05) | 80 (73.39) | 67 (63.21) | 0.238 |
| IV | 33 (28.95) | 29 (26.61) | 39 (36.79) | |
NPC – nasopharyngeal carcinoma; CT – chemotherapy; SRT – stereotactic radiotherapy. LNM – lymph node metastasis.